T. Rowe Price Investment Management Inc. Has $67.30 Million Holdings in Select Medical Holdings Corporation $SEM

Key Points

• T. Rowe Price Investment Management Inc. decreased its stake in Select Medical Holdings Corporation by 8.8%, now owning over 4 million shares valued at approximately $67.3 million.
• Select Medical recently declared a quarterly dividend of $0.0625 per share, corresponding to an annual dividend yield of 1.9%.
• Following recent reports, UBS Group and Royal Bank of Canada issued revised price targets for Select Medical, now set at $14.00 and $19.00 respectively, with the company holding a consensus rating of "Moderate Buy."

T. Rowe Price Investment Management Inc. reduced its stake in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 8.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,029,944 shares of the health services provider's stock after selling 389,195 shares during the period. T. Rowe Price Investment Management Inc. owned 3.14% of Select Medical worth $67,301,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Raymond James Financial Inc. purchased a new position in Select Medical in the 4th quarter valued at $5,858,000. Barclays PLC boosted its holdings in shares of Select Medical by 29.6% in the fourth quarter. Barclays PLC now owns 249,209 shares of the health services provider's stock valued at $4,698,000 after acquiring an additional 56,852 shares in the last quarter. First Trust Advisors LP increased its stake in shares of Select Medical by 106.0% during the fourth quarter. First Trust Advisors LP now owns 121,647 shares of the health services provider's stock worth $2,293,000 after acquiring an additional 62,592 shares during the period. Dimensional Fund Advisors LP raised its holdings in Select Medical by 1.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider's stock worth $83,533,000 after purchasing an additional 62,585 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its position in Select Medical by 6.7% in the fourth quarter. MetLife Investment Management LLC now owns 65,812 shares of the health services provider's stock valued at $1,241,000 after purchasing an additional 4,105 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Price Performance

Shares of SEM traded down $0.13 during mid-day trading on Thursday, hitting $12.92. The company's stock had a trading volume of 184,374 shares, compared to its average volume of 1,130,900. Select Medical Holdings Corporation has a fifty-two week low of $11.65 and a fifty-two week high of $40.98. The stock has a market capitalization of $1.60 billion, a price-to-earnings ratio of 12.18, a PEG ratio of 0.52 and a beta of 1.25. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15. The firm has a 50-day moving average price of $13.93 and a 200 day moving average price of $15.60.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The business had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the business earned $0.60 earnings per share. The firm's revenue was up 4.5% compared to the same quarter last year. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. On average, research analysts predict that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical declared that its board has approved a stock buyback plan on Thursday, May 1st that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its stock is undervalued.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Wednesday, August 13th will be issued a dividend of $0.0625 per share. The ex-dividend date is Wednesday, August 13th. This represents a $0.25 dividend on an annualized basis and a yield of 1.9%. Select Medical's payout ratio is currently 23.58%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. Royal Bank Of Canada decreased their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 7th. UBS Group reissued a "neutral" rating and set a $14.00 price target (down previously from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $20.25.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.